When a person’s hearing and vision are uncompromised and function at a relatively high level, the human brain is able to take in various sights and sounds from any environment and seamlessly allow said person to perceive what’s happening around them.

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by identifying not just which patient populations may benefit but also how the drugs work inside cells.

Dr. George Shaker has huge hopes for a small radar device he developed with a team of researchers at the University of Waterloo. An engineer who has pursued the possibilities of radio waves for more than 20 years, Shaker envisions the installation of the silent, unobtrusive system almost everywhere people sit to help detect heart problems before they become life-threatening.

Brain implants hold immense promise for restoring function in patients with paralysis, epilepsy and other neurological disorders. But a team of researchers at Case Western Reserve University has discovered that bacteria can invade the brain after a medical device is implanted, contributing to inflammation and reducing the device’s long-term effectiveness.

PARIS, March 18, 2025 /PRNewswire/ — Avatar Medical, a leader in immersive medical imaging, announces that it has obtained CE marking for its innovative solution, Avatar Medical Vision*. This certification marks a decisive step in the company’s mission to democratize access to medical images for both surgeons and patients. Avatar Medical Vision enables the real-time conversion of patient medical images into stunning 3D and XR renderings, enhancing visualization and understanding.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in the U.S.

Ypsomed and CamDiab today announced the launch of the mylife CamAPS FX app for automated insulin delivery on iOS platforms.

CAESAREA, Israel, March 17, 2025 /PRNewswire/ — IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure”, “IceCure Medical” or the “Company”), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it has received a Notice of Allowance for its invention titled “Cryogenic System Connector” from the China National Intellectual Property Administration.